Kaplan Quoted in Law360 Discussing the U.S. Department of Labor’s Emergency COVID-19 Safety Rule for Health Care Employers
18 June 2021
Partner Daniel Kaplan was quoted in a Law360 article titled, “3 Things Employers Should Know as DOL Virus Rule Kicks In,” discussing the Occupational Safety and Health Administration’s Emergency Temporary Standard taking effect and how it will affect employers.
Kaplan told Law360, “That’s got to be implemented within 14 days, and I think many health care locations have seen a reduction in the restrictions on family members and others who visit loved ones in the hospital. And they’re now going to have to [ramp] that back up because they’re going to have to now do screening and triage pretty much at any entry point. That’s going to create, I think, some backlog and some confusion.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”